26-008363 maxcyte expert GTX electroporation device and installation/operational qualification (IQ/OQ)
Ended Purchase Order Awarded
- Contract number
- 75N98026P01361
- Awardee
-
Maxcyte, Inc. UEI KM8DZV21HFM8
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $126,250
Award facts
- Opportunity
-
- MaxCyte ExPERT GTx Electroporation Device and Installation/Operational Qualification (IQ/OQ) Pre-Solicitation · 26008363 · Posted Jul 29, 2026
- Contract value 100% obligated
- $126,250.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- NIH Clinical Center National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The NIH Clinical Center awarded a purchase order to Maxcyte, Inc. valued at $126,250 on August 19, 2026, for a MaxCyte ExPERT GTx Electroporation Device (Generation 3) and Installation/Operational Qualification services. The procurement is firm fixed price with no set-aside. Performance occurs at the NIH Clinical Center in Rockville, Maryland. The Center for Cellular Engineering will deploy the device to introduce genetic material and proteins into cells during development and manufacturing of cell-based therapies under FDA Current Good Manufacturing Practices. The order includes the ExPERT GTx Flow Electroporation Platform for cGMP and clinical applications, IQ/OQ services and installation, and estimated freight. The award follows a sole-source pre-solicitation posted July 29, 2026, with an August 7, 2026 response deadline. Replacement was necessary because the current MaxCyte Gen2 GT system will no longer receive manufacturer support beginning mid-2026. Performance is due September 18, 2026.
Quick answers
Who was awarded contract 75N98026P01361?
75N98026P01361 was awarded to Maxcyte, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on August 19, 2026.
How much is contract 75N98026P01361 worth?
The government has obligated $126,250 on 75N98026P01361.
Which agency awarded contract 75N98026P01361?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P01361, with funding from NIH Clinical Center (National Institutes of Health).
Was contract 75N98026P01361 competed?
The extent of competition for 75N98026P01361 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award